SEATTLE - UW Medicine is looking for individuals who recently tested positive for COVID-19 to partake in a study.
The study is conducting research into four treatment therapies that include infusion, injection and an inhalant. Qualified applicants must have tested positive for COVID-19 within 10 days, in an outpatient setting, and must have begun to experience symptoms within a week of enrollment.
This study is included in the National Institutes of Health initiative to discover and accelerate Covid-19 treatments.
Director of the AIDS Clinical Trials Unit at Harborview Medical Center, Dr. Rachel Bender Ignacio, is leading the study.
For more information, visit UW Medicine.
Stay connected with Q13 News on all platforms: